eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | allergic bronchopulmonary aspergillosis |
| Comorbidity | C0006267|bronchiectasis |
| Sentences | 7 |
| PubMedID- 21603163 | If unrecognized or poorly treated, abpa leads to airway destruction, bronchiectasis, and/or pulmonary fibrosis, resulting in significant morbidity and mortality. |
| PubMedID- 23325730 | [non-cf bronchiectasis with focus on allergic bronchopulmonary aspergillosis]. |
| PubMedID- 24735832 | A 23 patient study of abpa patients without bronchiectasis treated with inhaled corticosteroids showed subjective improvement but without complete control of asthma and median ige levels increased [193]. |
| PubMedID- 22223932 | Eventually, type 2 respiratory failure, cor pulmonale, and right heart failure develop in end-stage fibrotic abpa, with extensive bronchiectasis and fibrosis on hrct of the chest. |
| PubMedID- 22167396 | Complications of abpa include bronchiectasis, typically central in distribution, and chronic pulmonary aspergillosis. |
| PubMedID- 24042528 | Development of allergic bronchopulmonary aspergillosis with central bronchiectasis over a 10-year period: the need to recheck allergen sensitization. |
| PubMedID- 19207831 | The prevalence of serological abpa (abpa without central bronchiectasis) was also higher in the asa group compared with the outpatient bronchial asthma group (45.4% vs. |
Page: 1